NOMIC BIO
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology. NPlex's platform and research provides cost-effective measurement of protein data with sample, fits seamlessly within industry cytometers for high-throughput analysis, and development of custom protein panels. It allows nanotechnology developers and businesses to bring improvement in existing instrument, workflow, and bring automation in the system.
NOMIC BIO
Industry:
Biotechnology Health Diagnostics Market Research Nanotechnology
Founded:
2017-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.nomic.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18.03 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Amazon Route 53 Amazon CloudFront
Current Advisors List
Current Employees Featured
Founder
Investors List
SR One
SR One investment in Series A - Nomic Bio
Casdin Capital
Casdin Capital investment in Series A - Nomic Bio
Lux Capital
Lux Capital investment in Series A - Nomic Bio
CQDM
CQDM investment in Grant - Nomic Bio
TechU Ventures
TechU Ventures investment in Seed Round - Nomic Bio
Front Row Ventures
Front Row Ventures investment in Venture Round - Nomic Bio
Uncommon Denominator
Uncommon Denominator investment in Venture Round - Nomic Bio
Y Combinator
Y Combinator investment in Venture Round - Nomic Bio
Y Combinator
Y Combinator investment in Pre Seed Round - Nomic Bio
First Star Ventures
First Star Ventures investment in Pre Seed Round - Nomic Bio
Official Site Inspections
http://www.nomic.bio
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nomic Bio"
Nomic - The Protein Profiling Company
Using DNA nanotechnology, we transformed the ELISA into a high-throughput proteomics technology. ~200 cytokines on-boarded to-date for comprehensive profiling of the immune …See details»
Nomic - Crunchbase Company Profile & Funding
Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and …See details»
Nomic Company Profile 2024: Valuation, Funding & Investors
Nomic is headquartered in Montreal, Canada. What is the size of Nomic? Nomic has 49 total employees. What industry is Nomic in? Nomic’s primary industry is Biotechnology. Is Nomic a …See details»
Nomic Company Profile: Overview and Full News Analysis
Sep 24, 2024 · Nomic is a company based in Quebec that specializes in protein profiling services, offering massively scalable, high fidelity, and flexible multiplexing using their innovative …See details»
Nomic - Crunchbase Company Profile & Funding
Nomic is located in Las Vegas, Nevada, United States. Who are Nomic's competitors? Alternatives and possible competitors to Nomic may include The FoodRoom, Yocale, and Cakemail. We're building a local job network, …See details»
Nomic® Secures $42M in Oversubscribed Series B to Expand …
Sep 17, 2024 · Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling. Montreal – September 17th, 2024 – Nomic Bio ("Nomic"), the Protein Profiling …See details»
Nomic Bio - LinkedIn
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a...See details»
Services - Nomic
10x your R&D output with best-in-class turnaround time, flexibility, and pricing. Using the nELISA, we built an industrial-scale, mail-in protein profiling service to support modern scientific teams. …See details»
Nomic Company Profile - Office Locations, Competitors, Revenue …
Nomic (formerly known as nplex Biosciences) is a bioengineering company developing a proteomics platform to understand, detect, and treat diseases. It uses DNA nanotechnology, …See details»
Nomic collects $17M to advance its automated, high …
Dec 8, 2021 · Launched by bioengineers from McGill University in Montreal, Nomic’s nELISA test relies on DNA nanotechnology, spectral multiplexing and automation to help quantify multiple proteins...See details»
Rebranded Nomic Bio raises $17 million to fuel …
Dec 8, 2021 · Nomic Bio has secured a new name and $17 million USD in Series A financing to support the growth of its protein-measuring platform. Nomic hopes to “revolutionize” how drugs are developed and diseases are diagnosed and …See details»
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) …
Sep 24, 2024 · Nomic is rapidly expanding its biological footprint to cover proteins across the entire proteome, unlocking new possibilities for diverse applications, uses cases, and disease …See details»
Nomic Closes $17 Million Series A to Develop and ... - BioSpace
Dec 8, 2021 · Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building …See details»
Nomic in $17M series A funding for high-throughput proteomic
Dec 8, 2021 · Protein profiling startup Nomic Bio has secured $17 million in an oversubscribed series A financing led by Lux Capital.See details»
Nomic - The Protein Profiling Company
Learn how Nomic's nELISA™ enables high-fidelity multiplexing, à-la-carte protein selection, and unmatched cost-efficiency. All using a white-glove service with end-to-end support and a 1 …See details»
Proteomics Firm Nomic Bio Closes $42M Series B Round
Sep 17, 2024 · NEW YORK — Proteomics firm Nomic Bio said Tuesday that it has closed a $42 million Series B funding round, led by an unnamed US-based investor with participation from …See details»
Technology - Nomic
Learn how Nomic's nELISA™ enables high-fidelity multiplexing, à-la-carte protein selection, and unmatched cost-efficiency. All using a white-glove service with end-to-end support and a 1 …See details»
Nomic Bio Counting on High Throughput to Generate Interest
Dec 9, 2021 · NEW YORK — With $17 million from a recently closed Series A funding round, proteomics firm Nomic Bio (formerly Nplex Bioscience) plans to launch services using its …See details»
Targets - Nomic
Learn how Nomic's nELISA™ enables high-fidelity multiplexing, à-la-carte protein selection, and unmatched cost-efficiency. All using a white-glove service with end-to-end support and a 1 …See details»
Nomic Closes $17 Million Series A to Develop and Commercialize …
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the …See details»